General Information of the Compound
| Compound ID |
CP0558300
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
N-[3-[(6R)-4-amino-2-cyano-6-methyl-7H-pyrazolo[1,5-a]pyrazin-6-yl]-4-fluorophenyl]-5-(fluoromethoxy)pyrazine-2-carboxamide
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C20H16F2N8O2
|
||||||||||||||||||
| Molecular Weight |
438.398
|
||||||||||||||||||
| Canonical SMILES |
C[C@]1(Cn2nc(cc2C(N)=N1)C#N)c1cc(NC(=O)c2cnc(OCF)cn2)ccc1F
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C20H16F2N8O2/c1-20(9-30-16(18(24)28-20)5-12(6-23)29-30)13-4-11(2-3-14(13)22)27-19(31)15-7-26-17(8-25-15)32-10-21/h2-5,7-8H,9-10H2,1H3,(H2,24,28)(H,27,31)/t20-/m0/s1
Show/Hide
|
||||||||||||||||||
| InChIKey |
ZXRHVPQEUUVSBF-FQEVSTJZSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01151, Amyloid-beta precursor protein
Protein ID: PT00897, Potassium voltage-gated channel subfamily H member 2